|
1
|
Di Nisio M, van Es N and Büller HR: Deep
vein thrombosis and pulmonary embolism. Lancet. 388:3060–3073.
2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lutsey PL and Zakai NA: Epidemiology and
prevention of venous thromboembolism. Nat Rev Cardiol. 20:1–15.
2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ma Y and Guo S: High expression of NADH
ubiquinone oxidoreductase subunit B11 induces catheter-associated
venous thrombosis on continuous blood purification. Medicine
(Baltimore). 102(e36520)2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Colling ME, Tourdot BE and Kanthi Y:
Inflammation, infection and venous thromboembolism. CircRes.
128:2017–2036. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Maaroof A and Wahab Z: Enhancing venous
thromboembolism risk prediction through novel biomarkers and
inflammatory indicators. J Appl Hematol. 15:313–318.
2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zeng J, Feng J, Luo Y, Wei H, Ge H, Liu H,
Zhang J, Li X, Pan P, Xie X, et al: Inflammatory biomarkers as
predictors of symptomatic venous thromboembolism in hospitalized
patients with AECOPD: A multicenter cohort study. J Atheroscler
Thromb. 32:439–457. 2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liu Y, Guo B, Meng Z, Fan Y, Xie Y, Gao L
and Ma R: Coagulation and inflammatory indicators in pneumonia
patients with venous thromboembolism: A propensity-score matching
study. J Inflamm Res. 18:5627–5635. 2025.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Swanson KV, Deng M and Ting JP: . The
NLRP3 inflammasome: molecular activation and regulation to
therapeutics. Nat Rev Immunol. 19:477–489. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bakirci EM, Topcu S, Kalkan K, Tanboga IH,
Borekci A, Sevimli S and Acikel M: The role of the nonspecific
inflammatory markers in determining the anatomic extent of venous
thromboembolism. Clin Appl Thromb. 21:181–185. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Potere N, Abbate A, Kanthi Y, Carrier M,
Toldo S, Porreca E and Di Nisio M: Inflammasome signaling,
thromboinflammation, and venous thromboembolism. JACC Basic Transl
Sci. 8:1245–1261. 2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Johnson AG, Wein T, Mayer ML, Duncan-Lowey
B, Yirmiya E, Oppenheimer-Shaanan Y, Amitai G, Sorek R and
Kranzusch PJ: Bacterial gasdermins reveal an ancient mechanism of
cell death. Science. 375:221–225. 2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang Y, Cui J, Zhang G, Wu C, Abdel-Latif
A, Smyth SS, Shiroishi T, Mackman N, Wei Y, Tao M and Li Z:
Inflammasome activation promotes venous thrombosis through
pyroptosis. Blood Adv. 5:2619–2623. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lu S, Lijuan R, Tang QH, Liu QL and
Xian-Lan Z: Bioinformatics analysis and identification of genes and
molecular pathways involved in venous thromboembolism (VTE). Ann
Vasc Surg. 74:389–399. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chen H, Luo H, Wang J, Li J and Jiang Y:
Identification of a pyroptosis-related prognostic signature in
breast cancer. BMC Cancer. 22(429)2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z,
Feng T, Zhou L, Tang W and Zhan L: ClusterProfiler 4.0: A universal
enrichment tool for interpreting omics data. Innovation (Camb).
2(100141)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang Z, Zhang Z, Zhang K, Zhou Q, Chen S,
Zheng H, Wang G, Cai S, Wang F and Li S: Multi-omics
characterization of a glycerolipid metabolism-related gene
enrichment score in colon cancer. Front Oncol.
12(881953)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9(559)2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cheng Q, Chen X, Wu H and Du Y: Three
hematologic/immune system-specific expressed genes are considered
as the potential biomarkers for the diagnosis of early rheumatoid
arthritis through bioinformatics analysis. J Transl Med.
19(18)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Tan Z, Li F, Chen Q, Chen H, Xue Z, Zhang
J, Gao Y, Liang L, Huang T, Zhang S, et al: Integrated bulk and
single-cell RNA-sequencing reveals SPOCK2 as a novel biomarker gene
in the development of congenital pulmonary airway malformation.
Respir Res. 24(127)2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wu X, Qin K, Iroegbu CD, Xiang K, Peng J,
Guo J, Yang J and Fan C: Genetic analysis of potential biomarkers
and therapeutic targets in ferroptosis from coronary artery
disease. J Cell Mol Med. 26:2177–2190. 2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang L, Qin J and Li P: Bioinformatics
analysis of potential common pathogenic mechanisms for COVID-19 and
venous thromboembolism. Cytokine. 181(156682)2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Fatica A and Tollervey D: Making
ribosomes. Curr Opin Cell Biol. 14:313–318. 2002.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Roberts E, Sethi A, Montoya J, Woese CR
and Luthey-Schulten Z: Molecular signatures of ribosomal evolution.
Proc Natl Acad Sci U S A. 105:13953–1398. 2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Wu F, Liu Y, Hu S and Lu C: Ribosomal
protein L31 (RPL31) inhibits the proliferation and migration of
gastric cancer cells. Heliyon. 9(e13076)2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wei F, Ding L, Wei Z, Zhang Y, Li Y,
Qinghua L, Ma Y, Guo L, Lv G and Liu Y: Ribosomal protein L34
promotes the proliferation, invasion and metastasis of pancreatic
cancer cells. Oncotarget. 51:85259–85272. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Baik IH, Jo GH, Seo D, Ko MJ, Cho CH, Lee
MG and Lee YH: Knockdown of RPL9 expression inhibits colorectal
carcinoma growth via the inactivation of Id-1/NF-κB signaling axis.
Int J Oncol. 49:1953–1962. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Watanabe M, Toyomura T, Wake H, Nishinaka
T, Hatipoglu OF, Takahashi H, Nishibori M and Mori S:
Identification of ribosomal protein L9 as a novel regulator of
proinflammatory damage-associated molecular pattern molecules. Mol
Biol Rep. 49:2831–2838. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Xiong X, Zhao Y, He H and Sun Y: Ribosomal
protein S27-like and S27 interplay with p53-MDM2 axis as a target,
a substrate and a regulator. Oncogene. 30:1798–1811.
2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Xiong X, Cui D, Bi Y, Sun Y and Zhao Y:
Neddylation modification of ribosomal protein RPS27L or RPS27 by
MDM2 or NEDP1 regulates cancer cell survival. The FASEB J.
34:13419–13429. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Genovese G, Ghosh P, Li H, Rettino A,
Sioletic S, Cittadini A and Sgambato A: The tumor suppressor HINT1
regulates MITF and β-catenin transcriptional activity in melanoma
cells. CellCycle. 11:2206–2215. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
32
|
Dillenburg M, Smith J and Wagner CR: The
many faces of histidine triad nucleotide binding protein 1 (HINT1).
ACS Pharmacol. Transl. Sci. 6:1310–1322. 2023.PubMed/NCBI View Article : Google Scholar
|
